Tesaro Inc’s ovarian cancer drug niraparib approved by FDA

News Hour:

The U.S. Food and Drug Administration on Monday approved Tesaro Inc’s drug, niraparib, for the treatment of recurrent ovarian cancer.

Epithelial ovarian, fallopian tube or primary peritoneal cancer affects the tissue covering the ovary or lining of the fallopian tube or abdominal wall, reports Reuters.

Avatar

This article has been posted by a News Hour Correspondent. For queries, please contact through [email protected]
No Comments

Translate this News

Join the Facebook Group

Click here to join the Facebook group of News Hour

Popular Posts

Sacred Games exposes Rajshri Deshpande nude [video]
The miracle of Hyperbaric Oxygen Therapy (HBOT) and its potential in Bangladesh
Anurag Kashyap shoots Kubra Saith 7 times nude and made her cry for frontal nudity scene [Video]
Marriott's acquisition of starwood has antitrust authorization from saudi arabia and mexico
Update on China's ministry of commerce review of Marriott and Starwood merger
Paperfly launches delivery services covering 64 districts in Bangladesh

Advertisement

News of the Month

Scroll Up
%d bloggers like this: